Page 1 of 2
12

Kelsh MA, Bracken TD, Sahl JD, Shum M, Ebi KL. 2003. Occupational magnetic field exposures of garment workers: Results of personal and survey measurements. Bioelectromagnetics 24:316–326.

View Abstract

Liu L, Zwingman TA, Fletcher CF. 2003. In vivo analysis of voltage dependent calcium channels (review). J Bioenerg Biomembr 35:1051–1068.

View Abstract

Birnbaum LS, Staskal DF, and Diliberto JJ. 2003. Health effects of polybrominated dibenzo-p-dioxins (PBDDs) and dibenzofurans (PBDFs). Environ Inter. 29: 855-860.

Haws, L. Combustion risk modeling and assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion. May 7, 2003. Austin, TX.

Perry, C.S. Process for development of protective concentration levels for remediation sites in Texas.Presented at Society for Environmental Toxicology and Chemistry (SETAC) meeting. November 9-13, 2003. Austin, TX.

Cappon GD, Fleeman TL, Rocca MS, Cook JC, Hurtt ME. 2003. Embryo/fetal development studies with hydroxypropyl methylcellulose acetate succinate (HPMCAS) in rats and rabbits. Birth Defects Res (Part B)
68:421–427, DOI: 10.1002/bdrb.10039, online article.

View Abstract

Wood SL, Beyer B, Cappon GD. 2003. Species comparison of postnatal CNS development: Functional measures. Birth Defects Res (Part B) 68:391–407, DOI: 10.1002/bdrb.10037, online article.

View Abstract

Staskal, D.F., M.J. DeVito, D.G. Ross, and L.S. Birnbaum. 2003. A Comparison of the metabolism of methoxyresorufin, acetanilide, and caffeine in rat and human CYP1A2 SUPERSOMES. The Toxicologist.

McMillan DA, Mahony C, Patel LB, Zhou X, Bailey RE, Walden GL. Salivary peroxide kinetics with 6% hydrogen peroxide whitening strips. J Dent Res 82(B-143), 2003.

Gerlach RW, Zhou X, McMillan DA. Safety of vital bleaching with 6% hydrogen peroxide whitening strips: Evidence from 18 clinical trials. J Dent Res 82(B-143), 2003.

Staskal, D.F., M.J. DeVito, D.G. Ross, and L.S. Birnbaum. 2003. Caffeine, Acetanilide, and Methoxyresorufin Metabolism by Rat and Human CYP1A2 SUPERSOMES and their Inhibition by 2,3,7,8,-Tetrachlorodibenzo-p-dioxin (TCDD). Organohalogen Compounds.

Gentry RP, Covington TR, Clewell HJ III. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul Toxicol Pharmacol 38:1–16.

View Abstract

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Window of susceptibility to perfluorooctane sulfonate (PFOS)-induced neonatal mortality in the rat. Birth Defects Research, Part B, 68(3), 5.

Proctor D, Panko J, Liebig E, Mundt K, Buczynski M, Barnhart R, Harris MA, Morgan R, Finley B, Paustenbach D. 2003. Workplace concentrations of airborne hexavalent chromium for the Painesville, Ohio chromate production plant. Appl Occ Environ Hyg J 18(6):430-449.

Panko JM. Mold problems in buildings. Solving water intrusion and mold problems in Pennsylvania. Lorman Education Services, Altoona, PA, November 5, 2003.

Panko JM. AWMA/Healthy Indoor Partnerships. International Conference on Indoor Air Quality/Health Indoor Environment, Mold Contamination Case Studies, 2003.

Panko JM, Shay EC, Unice KM. Risk perception: The reoccupancy of Lower Manhattan office space following the national tragedies of September 11, 2001. Poster at the Society for Risk Analysis Annual Conference, December 2003.

Luippold RS, Mundt KA, Austin RP, Liebig EW, Panko JM, Crump C, Crump K, Proctor DM. 2003. Lung cancer mortality among chromate production workers. J Occup Environ Med 60:451–457.

View Abstract

Crump C, Crump K, Hack E, Luippold R, Mundt K, Liebig EW, Panko JM, Paustenbach DJ, Proctor DM. 2003. Dose-response and risk assessment of airborne hexavalent chromium and lung cancer mortality. Risk Anal 23(6):1147–1163.

View Abstract

Scott P, Petura J, and Harris MA. 2003. Derivation of a liquid to solid ratio for ASTM method D3987 85 for soils containing chromite ore processing residue using selected unsaturated zone models. Soil Sed Contam. 12(4):443-480.

Page 1 of 2
12